What rates 80% for Renal Cell Carcinoma under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 80% rating for Renal Cell Carcinoma requires: Chronic kidney disease with GFR from 15 to 29 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

What rates 60% for Renal Cell Carcinoma under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 60% rating for Renal Cell Carcinoma requires: Chronic kidney disease with GFR from 30 to 44 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

What rates 30% for Renal Cell Carcinoma under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 30% rating for Renal Cell Carcinoma requires: Chronic kidney disease with GFR from 45 to 59 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

← All Condition Guides

CLAIM RECON INTEL

Renal Cell Carcinoma

Q: What are the VA rating percentages for Renal Cell Carcinoma?

Renal Cell Carcinoma (DC 7528) is rated at 100%, 80%, 60%, 30%, 0% under 38 CFR § 4.115b, DC 7528. Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient

Q: What rates 100% for Renal Cell Carcinoma under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 100% rating for Renal Cell Carcinoma requires: Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient

Q: What rates 0% for Renal Cell Carcinoma under 38 CFR § 4.115b, DC 7528?

Under 38 CFR § 4.115b, DC 7528 (DC 7528), a 0% rating for Renal Cell Carcinoma requires: GFR from 60 to 89 mL/min/1.73 m2 and either recurrent red blood cell (RBC) casts, white blood cell (WBC) casts, or granular casts for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m2 and structural kidney abnormalities (cystic, obstructive, or glomerular) for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m2 and albumin/creatinine ratio (ACR) ≥30 mg/g for at least 3 consecutive months during the past 12 months

Q: What evidence do I need for a Renal Cell Carcinoma VA claim?

Key evidence for a Renal Cell Carcinoma claim includes: A voiding diary recording pad/appliance changes per day, daytime voiding intervals, and nighttime awakenings; Lab reports showing GFR or eGFR across at least 3 consecutive months (renal dysfunction); Urology records showing post-void residual volume, uroflowmetry peak flow, or catheterization needs; Records of recurrent UTIs, including hospitalizations and any suppressive drug therapy; Imaging or operative reports confirming the genitourinary diagnosis. All evidence should document both the condition and its impact on daily functioning.

DC 752838 C.F.R. § 4.115b

Diagnostic Code

DC 7528

38 C.F.R. § 4.115b

Rating Range

0–100%

5 severity tiers

Source

Verified

38 C.F.R. § 4.115b

Renal Cell Carcinoma is rated by the U.S. Department of Veterans Affairs under DC 7528 of 38 CFR § 4.115b, DC 7528 across 5 severity tiers (100% / 80% / 60% / 30% / 0%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Most common type of kidney cancer in adults. Rated 100% during active disease. After treatment, rated on residuals including kidney function and voiding dysfunction. Associated with Agent Orange and burn pit exposure.

Rating Criteria

100%

Chronic kidney disease with glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months; or requiring regular routine dialysis; or eligible kidney transplant recipient

80%

Chronic kidney disease with GFR from 15 to 29 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

60%

Chronic kidney disease with GFR from 30 to 44 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

30%

Chronic kidney disease with GFR from 45 to 59 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months

GFR from 60 to 89 mL/min/1.73 m2 and either recurrent red blood cell (RBC) casts, white blood cell (WBC) casts, or granular casts for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m2 and structural kidney abnormalities (cystic, obstructive, or glomerular) for at least 3 consecutive months during the past 12 months; or GFR from 60 to 89 mL/min/1.73 m2 and albumin/creatinine ratio (ACR) ≥30 mg/g for at least 3 consecutive months during the past 12 months

Key Evidence

—A voiding diary recording pad/appliance changes per day, daytime voiding intervals, and nighttime awakenings

—Lab reports showing GFR or eGFR across at least 3 consecutive months (renal dysfunction)

—Urology records showing post-void residual volume, uroflowmetry peak flow, or catheterization needs

—Records of recurrent UTIs, including hospitalizations and any suppressive drug therapy

—Imaging or operative reports confirming the genitourinary diagnosis

—Complete list of genitourinary medications

C&P Exam Tips

1If your condition causes voiding dysfunction, the rating often turns on absorbent materials or appliance use (38 CFR 4.115a) - count and report how many times per day you change a pad or appliance (more than 4x/day supports the highest level).

2For urinary frequency, document your daytime voiding interval and how many times you wake to void at night - both are explicit thresholds.

3For obstructed voiding, ask whether your record shows post-void residual volume, peak flow rate (uroflowmetry), or a need for catheterization.

4If the kidneys are involved, the rating is driven by GFR (38 CFR 4.115a) - request an eGFR lab and note that it must persist for at least 3 consecutive months in the past 12 months.

5For recurrent urinary tract infections, document drainage by stent/nephrostomy, hospitalizations per year, and any continuous/suppressive drug therapy.

6Report your worst days, bring a voiding diary, and describe how the condition affects sleep, work, and daily activity.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.115b (Genitourinary system — diagnoses). Source verified 2026-06-04 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.115b on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING